Pharmaids Pharmaceuticals Ltdte Share Price & Stock Analysis

Pharmaids Pharmaceuticals Ltdte (BSE: 524572) is a Bengaluru, Karnataka-based company in the Pharmaceutical Contract Manufacturing Services industry. With a market capitalisation of ₹105 Cr, it ranks #3,201 by market cap among the 6,197 Indian listed companies on FinBizNet, and #15 of 26 in Pharmaceutical Contract Manufacturing Services. At ₹28.50 (as of 16 Nov 2026), the share price is 47.1% below its 52-week high of ₹53.90 and 11.3% above its 52-week low of ₹25.60. The share price is down 39.4% over one year and down 16.2% over three months.

Key Metrics

Current Price₹28.50
Market Cap₹105 Cr
BSE Code524572
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryPharmaceuticals > Pharmaceutical Contract Manufacturing Services
P/E RatioNot meaningful (loss)
Return on Equity-17.82%
Return on Assets-9.39%
52-Week Range₹25.60 – ₹53.90
1-Year Price Change-39.4%
3-Month Price Change-16.2%
Beta (1Y)-0.15
HeadquartersBengaluru, Karnataka
Websitewww.pharmaids.com

Latest Quarterly Results — Q1 FY27

Revenue₹0 Cr
Net Profit₹2 Cr
EPS (Basic)₹0.61
Basisstandalone

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Pharmaids Pharmaceuticals Ltdte Quarterly Revenue and Profit Trend

Pharmaids Pharmaceuticals Ltdte reported revenue of ₹0 Cr in Q1 FY27, down 100.0% from ₹1 Cr in Q1 FY26 and down 100.0% from ₹3 Cr in Q4 FY26. It posted a net profit of ₹2 Cr for the quarter, against a net loss of ₹4 Cr in Q1 FY26. Across the 8 quarters from Q2 FY25 to Q1 FY27, quarterly revenue ranged from ₹0 Cr (Q1 FY27) to ₹6 Cr (Q2 FY26). The company reported a net loss in 7 of these 8 quarters.

QuarterRevenueNet ProfitNet Margin
Q1 FY27₹0 Cr₹2 Cr—
Q4 FY26₹3 Cr−₹1 Cr−48.7%
Q3 FY26₹1 Cr−₹3 Cr−374.7%
Q2 FY26₹6 Cr−₹2 Cr−27.6%
Q1 FY26₹1 Cr−₹4 Cr−389.3%
Q4 FY25₹0 Cr−₹3 Cr−2353.8%
Q3 FY25₹1 Cr−₹2 Cr−131.4%
Q2 FY25₹1 Cr−₹1 Cr−121.7%

Standalone figures (₹ crore, XBRL filings).

Shareholding and Delivery

Delivery averaged 82.8% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).

About Pharmaids Pharmaceuticals Ltdte

Pharmaids Pharmaceuticals Limited, together with its subsidiaries, provides contract research and manufacturing services for pharma, biotech, agro, and chemical industries in India. The company offers pharma intermediates, such as Dichloro Benzoyl nitrile, hydrazine carboximidamide 2 methane, pyridine carbonitrile,pyridine carboxylic acid, 8-chloro-10, 11-dihydro-4-aza-5H-dibenzo cycloheptene-5-one, 8-chloro-6,11-dihydro-11 cyclohepta pyridine,2-amino-5-methylthiopene-3-carbonitrile, 5-methyl-2-amino]thiophene-3-carbonitrile, 4-amino-2-methyl-10h-thiene benzodiazepine hydrochloride, 2,4-diamino-6-chloropyrimidine, hydronopol, squalene, 5-chloro-3-phenylanthranil, 2-amino-2,5-dichlorobenzophenone, 6-fluoro-3-4-piperidinyl-1,2-benzisoxazole hcl, 3-2-methyl-4H-pyrido pyrimidin-4-one, 4-n-hexyl resorcinol, triazole kopoxil, CAB-60, CABER-4, CAB-70, DTV, and avobenzone. It also provides active pharmaceuticals ingredients, including voglibose, silodosin, vitamin K2-7, UDCA, P5P, fluralaner,

Products and Services

1. Manufacturing and Selling of Drugs Formulation-This segment produces and markets pharmaceutical formulations in India. It offers allopathic, herbal ayurvedic, and natural drug formulations in various forms, such as tablets, capsules, liquids, powders, etc.

Business Segments

1. Providing Contract Research and Manufacturing Services-100%

Pharmaids Pharmaceuticals Ltdte vs Peers — Pharmaceutical Contract Manufacturing Services

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Torrent Pharma Ltd.₹1,79,494 Cr73.616.98%₹4,979 Cr+30.4%
Aether Industries Limited₹21,710 Cr101.89.81%₹347 Cr+127.8%
Alivus Life Sciences Ltd₹17,862 Cr31.518.36%₹682 Cr+64.0%
Aarti Pharmalabs Ltd₹8,374 Cr52.58.49%₹610 Cr+15.4%
Solara Active Pharma Sciences Limited₹3,225 Crn/m-0.63%₹417 Cr+22.1%
Sai Parenteral's Limited₹2,235 Cr115.82.88%₹195 Cr—
KRM Ayurveda Limited₹521 Cr25.917.54%₹32 Cr—
Trident Lifeline Limited₹511 Cr26——+37.6%
Pharmaids Pharmaceuticals Ltdte₹105 Crn/m-17.82%₹0 Cr-39.4%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Pharmaids Pharmaceuticals Ltdte?

Pharmaids Pharmaceuticals Ltdte is trading at ₹28.50, with a market capitalisation of ₹105 Cr.

Which sector does Pharmaids Pharmaceuticals Ltdte belong to?

Pharmaids Pharmaceuticals Ltdte operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Contract Manufacturing Services).

What are the key financial ratios of Pharmaids Pharmaceuticals Ltdte?

Pharmaids Pharmaceuticals Ltdte has a return on equity of -17.82%.

What is the stock symbol of Pharmaids Pharmaceuticals Ltdte?

Pharmaids Pharmaceuticals Ltdte is listed on the BSE under the scrip code 524572.

How has Pharmaids Pharmaceuticals Ltdte's share price moved over the past year?

Pharmaids Pharmaceuticals Ltdte's share price is down 39.4% over one year and down 16.2% over three months. Its 52-week range is ₹25.60 to ₹53.90.

What were Pharmaids Pharmaceuticals Ltdte's latest quarterly results?

In Q1 FY27, Pharmaids Pharmaceuticals Ltdte reported revenue of ₹0 Cr and net profit of ₹2 Cr, with basic EPS of ₹0.61 (standalone, parsed from the company's exchange filing).

How have Pharmaids Pharmaceuticals Ltdte's revenue and profit changed over the past year?

Pharmaids Pharmaceuticals Ltdte reported revenue of ₹0 Cr in Q1 FY27, down 100.0% from ₹1 Cr in Q1 FY26 and down 100.0% from ₹3 Cr in Q4 FY26.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.